In 1981 three northern European families were described in which a severely mentally retarded son also had haemoglobin H (Hb H) disease.' These findings were of interest because Hb H disease, a relatively severe manifestation of a thalassaemia, is rare in northern Europeans although it is frequently seen in Mediterranean and Oriental racial groups in which it is not known to be associated with an increased frequency of mental retardation. Furthermore, whereas the common forms of Hb H disease are always inherited in a mendelian fashion, in these northern European families this appeared not to be so.
Hb H disease occurs when a greater than 50% reduction in synthesis of the a globin chains of adult haemoglobin (Hb A, a212) results in the accumulation of excess 1 globin chains which form 14 tetramers (Hb H). The common mendelian forms of Hb H disease result from mutations of both allelic a globin complexes, most commonly owing to deletions or less frequently to small rearrangements or point mutations. The a globin complex is located close to the telomere of the short arm of chromosome 16, within band 16pl3. 3. By 1990, a total of 13 subjects with a thalassaemia and mental retardation (ATR) had been identified and two distinct syndromes were delineated.34 Eight patients had large (1 to 2 megabases) deletions of the tip of chromosome 16p; the clinical features of this so called ATR-16 syndrome were rather variable, in part because some patients had additional chromosomal aneuploidy. By contrast, the five other patients (four boys and one XY female), in whom no deletion or other abnormalities of the a globin complex could be detected, had a remarkably uniform phenotype, comprising severe mental retardation, characteristic dysmorphic facies, genital abnormalities, and an unusual, mild form of Hb H disease. It was proposed that these five 'non-deletion' cases represented a distinct syndrome that probably mapped to the X chromosome.
Evidence from two additional families57 has subsequently strengthened the suggestion that these non-deletion cases represent a distinct and recognisable X linked syndrome which has been named the X linked ATR syndrome (ATR-X).7 The three case reports in this issue consolidate the evidence for X linkage and extend knowledge of the clinical and haematological phenotype of the affected subjects. In addition, they provide some important, provisional observations on the phenotype of carriers of this disorder. This review summarises the findings in the 16 cases published to date. 4'0 The clinical features of the ATR-X syndrome In all cases of the ATR-X syndrome mental handicap is severe, global, and apparent from an early age. Usually the pregnancy and delivery are without complications and the birth weight is normal. However, hypotonia and feeding difficulty are commonly apparent in the first few days of life and all developmental milestones are subsequently delayed. Sitting is usually delayed and, at best, walking starts in the third year; in four cases walking has not been achieved by adulthood. Speech is absent in all but one case'0 and even then is limited to a few words; comprehension is usually very poor. None has achieved more than partial bowel or bladder control.
Other abnormal neurological findings have been observed but none appears to be specific to this syndrome. Seizures occur in seven of the patients. cells after incubation with 1% BCB. This examination is best performed on a fresh sample of blood and the efficacy with which Hb H inclusions can be found may depend on the batch and freshness of the preparation of BCB used. We have found that incubation is best performed at room temperature; incubation at 37GC may occasionally induce very rare artefactual inclusions similar to those seen in a thalassaemia (see reference 9 for example). However, this situation will not be confused with the appearance in affected boys in whom Hb H inclusions can be shown in many red cells (greater than one per high power field).
The evidence for an X encoded syndrome Analysis of the a globin complex in patients with the ATR-X syndrome has indicated no abnormality. Figure 1 Haemoglobin levels in subjects with the A TR-X syndrome at various ages. Solid line indicates the mean and dashed line 2 SD below the mean." Results are divided into those cases that were ascertained haematologically or phenotypically. For any subject only one result within each consecutive 5 year period is given and no results below the age of 6 months are included. Further evidence that the defect is not located within the a globin complex has come from analysis of a family with four affected brothers.'0 The parental a globin 3'HVR alleles can be seen to assort independently in the four boys.
Since expression of the a globin genes, as judged by mRNA analysis and protein synthesis, is reduced to less than 50% of normal' 4 it seemed possible that both alleles were down regulated by a common trans acting mechanism. To analyse this situation further the maternal and paternal chromosomes 16 from one patient were isolated in trans specific (human x mouse erythroleukaemia cell) hybrids.4 Human a globin synthesis was readily detected in both hybrids and furthermore both expressed al and a2 mRNA in a manner indistinguishable from that of a hybrid containing a normal chromosome 16. The simplest explanation for these findings is that expression of all four a genes in patients with the ATR-X syndrome is down regulated by a new abnormality in a trans acting factor that interacts with the regulatory sequences of the a globin cluster. Because expression of the a globin genes appears normal in the mouse erythroleukaemia cells, it is presumed that the genetic defect is complemented by the mouse background.
Where might the locus encoding such a factor lie? Circumstantial evidence favouring X linkage was presented in the initial report of the ATR-X syndrome.4 All five original cases were 46,XY including one phenotypic female. It was also noted that occasional Hb H inclusions could be seen in one female sib who was otherwise entirely normal. Since then, as summarised by Wilkie et al,7 two recent papers have added further support to this conclusion. Harvey et aP described the probable occurrence of two affected males in a sibship. Porteous and Burn6 described a 6 year old boy, subsequently identified as having the ATR-X syndrome, whose dead maternal uncle had similar clinical features and had been anaemic throughout life.
The three families reported in this issue"'0 extend these observations. All nine affected subjects are male. In each family there is more than one affected boy but male to male transmission is not seen in any of the families. In one family' a high frequency of miscarriage and deaths of known males in utero has been documented; in this and one other pedigree9 there appears to be a paucity of normal liveborn males. To date no karyotypic abnormalities involving the X chromosome have been noted in this syndrome. 
